|
deep brain stimulation |
8 |
|
hippocampus |
8 |
|
neurogenesis |
8 |
|
anxiety |
7 |
|
memory |
7 |
|
melatonin |
6 |
|
neuromodulation |
6 |
|
alzheimer's disease |
5 |
|
alzheimer’s disease |
5 |
|
dementia |
5 |
|
depression |
5 |
|
fmri |
5 |
|
low frequency |
5 |
|
optogenetic |
5 |
|
resting-state functional connectivity |
5 |
|
animal model |
4 |
|
electrical stimulation |
4 |
|
learning and memory |
4 |
|
major depressive disorder |
4 |
|
neuroanatomy |
4 |
|
neuroplasticity |
4 |
|
stem cells |
4 |
|
aged |
3 |
|
ageing |
3 |
|
dna methylation |
3 |
|
dopamine |
3 |
|
dysfunction |
3 |
|
elevated plus maze |
3 |
|
embryonic stem cells |
3 |
|
entorhinal |
3 |
|
fear |
3 |
|
home cage emergence test |
3 |
|
huntington's disease |
3 |
|
immunohistochemistry |
3 |
|
induced pluripotent stem cells |
3 |
|
medial prefrontal cortex |
3 |
|
mesenchymal stem cells |
3 |
|
microarray |
3 |
|
mitochondrial dysfunction |
3 |
|
monoaminergic |
3 |
|
morphology |
3 |
|
network |
3 |
|
neural stem cells |
3 |
|
neurodegenerative disease |
3 |
|
neuroepigenetics |
3 |
|
neuronal nitric oxide synthase |
3 |
|
neuroprotection |
3 |
|
neurotransmission |
3 |
|
parkinson's disease |
3 |
|
periaqueductal gray |
3 |
|
perifornical |
3 |
|
preclinical |
3 |
|
rd10 |
3 |
|
retinal degeneration |
3 |
|
stem cell therapy |
3 |
|
stem cell transplantation |
3 |
|
subcallosal cingulate |
3 |
|
treatment-resistant depression |
3 |
|
visual cortex |
3 |
|
young |
3 |
|
aging |
2 |
|
anhedonia |
2 |
|
anti-neuroinflammatory |
2 |
|
antidepressant |
2 |
|
antidepressant-like behaviours |
2 |
|
autophagy |
2 |
|
buspirone |
2 |
|
cerebellar ataxia |
2 |
|
chronic mild stress (cms) |
2 |
|
circadian rhythm |
2 |
|
differentiation |
2 |
|
dpscs |
2 |
|
dropout |
2 |
|
fear-like behaviour |
2 |
|
forced swimming |
2 |
|
gmscs |
2 |
|
hericium erinaceus |
2 |
|
impulsivity |
2 |
|
lion’s mane mushroom |
2 |
|
mood disorders |
2 |
|
motor deficits |
2 |
|
neural network |
2 |
|
obsessive-compulsive disorder |
2 |
|
orexin |
2 |
|
panic |
2 |
|
prelimbic cortex |
2 |
|
scaps |
2 |
|
sleep |
2 |
|
sucrose test |
2 |
|
vagus nerve stimulation |
2 |
|
102t-c |
1 |
|
5-ht1a |
1 |
|
ablative surgery |
1 |
|
ace2 negative |
1 |
|
actin cytoskeleton |
1 |
|
addiction |
1 |
|
age-related macular degeneration |
1 |
|
aggression |
1 |
|
agoraphobia |
1 |
|
agosaphobia |
1 |
|
amygdala |
1 |
|
amyloid beta |
1 |
|
angiogenesis |
1 |
|
animal models |
1 |
|
anticipatory anxiety |
1 |
|
antidepressants |
1 |
|
antioxidant |
1 |
|
antioxidants |
1 |
|
anxiety conditions |
1 |
|
anxiolytics |
1 |
|
astrogliosis |
1 |
|
attention-deficit/hyperactivity disorder (adhd) |
1 |
|
authenticity |
1 |
|
autism spectrum disorder (asd) |
1 |
|
aβ |
1 |
|
basal ganglia |
1 |
|
behaviour |
1 |
|
behavioural manipulation |
1 |
|
brain |
1 |
|
brain‐derived neurotrophic factor |
1 |
|
c-fos immunoreactivity |
1 |
|
cas 33386-08-2 |
1 |
|
cell transplantation |
1 |
|
cerebellum |
1 |
|
cerebral ventricles |
1 |
|
chorea |
1 |
|
cilia |
1 |
|
cingulate gyrus (cg) |
1 |
|
circuit of papez |
1 |
|
cognitive flexibility |
1 |
|
complementary and alternative medicines |
1 |
|
complementary medicine |
1 |
|
conditioned fear |
1 |
|
corticosterone |
1 |
|
covid-19 |
1 |
|
deep brain stimulation c-fos |
1 |
|
defensive |
1 |
|
defensive behavior |
1 |
|
delay discounting |
1 |
|
depression mimicking |
1 |
|
dermal fibroblasts |
1 |
|
dopamine depletion |
1 |
|
dorsal raphe nucleus |
1 |
|
electroconvulsive therapy |
1 |
|
electroencephalogram (eeg) |
1 |
|
endogenous antioxidant |
1 |
|
endoplasmic reticulum |
1 |
|
enthorhinal cortex |
1 |
|
entorhinal cortex |
1 |
|
er stress |
1 |
|
escape behaviour |
1 |
|
estradiol |
1 |
|
existentialism |
1 |
|
experimental |
1 |
|
extraversion |
1 |
|
eyeblink |
1 |
|
flexibility |
1 |
|
food intake |
1 |
|
forced swim task |
1 |
|
forebrain |
1 |
|
fornix |
1 |
|
freezing behaviour |
1 |
|
friedreich’s ataxia |
1 |
|
function recovery |
1 |
|
funding |
1 |
|
gaba |
1 |
|
genetic |
1 |
|
germinal matrix hemorrhage |
1 |
|
glial cells |
1 |
|
global burden of disease |
1 |
|
golden mean |
1 |
|
government restrictions |
1 |
|
hedonia |
1 |
|
herbal formulation |
1 |
|
hereditary ataxia |
1 |
|
high frequency stimulation |
1 |
|
high-frequency stimulation |
1 |
|
high-frequency stimulation (hfs) |
1 |
|
histone modification |
1 |
|
htr2a |
1 |
|
huntington disease |
1 |
|
hydrocephalus |
1 |
|
hypermobility |
1 |
|
hypothalamic-pituitary-adrenal axis |
1 |
|
hypothalamus |
1 |
|
hypoxic-ischemia injury |
1 |
|
immunomodulation |
1 |
|
impact factor |
1 |
|
impulsive behavior |
1 |
|
insulin receptor (ir) |
1 |
|
intracranial hemorrhage |
1 |
|
kirschner's knitting needle |
1 |
|
lactosylceramide alpha-2,3-sialyltransferase (st3gal5) |
1 |
|
learning |
1 |
|
limbic system |
1 |
|
longitudinal columns |
1 |
|
major brain gangliosides |
1 |
|
maxillomandibular |
1 |
|
medicinal mushroom |
1 |
|
medicinal plant |
1 |
|
mediodorsal thalamic nucleus |
1 |
|
memory enhancement |
1 |
|
memory extinction |
1 |
|
metrics |
1 |
|
mice |
1 |
|
microalgae |
1 |
|
microglia |
1 |
|
middle cranial cavity |
1 |
|
mitochondrial function |
1 |
|
monoamines |
1 |
|
motivation |
1 |
|
n-wasp |
1 |
|
natural products |
1 |
|
natural remedy |
1 |
|
nerve regeneration |
1 |
|
nerve repair |
1 |
|
neuroinflammation |
1 |
|
neurological |
1 |
|
neuronal nitric oxide synthase (nnos) |
1 |
|
neurosurgery |
1 |
|
nitric oxide synthase |
1 |
|
nucleus accumbens |
1 |
|
nucleus accumbens (nac) |
1 |
|
nucleus basalis of meynert |
1 |
|
oxidative damage |
1 |
|
oxidative stress |
1 |
|
panic disorder |
1 |
|
panic-like behaviour |
1 |
|
papez circuit |
1 |
|
parasites |
1 |
|
parvalbumin |
1 |
|
pathophysiology |
1 |
|
periaqueductal |
1 |
|
periaqueductal grey |
1 |
|
peripheral nerve injury |
1 |
|
posthemorrhagic hydrocephalus |
1 |
|
premature responding |
1 |
|
premature responding reaction time task |
1 |
|
prematurity |
1 |
|
probabilistic learning |
1 |
|
proteolipid protein 1 (plp1) |
1 |
|
psychiatric |
1 |
|
psychiatry |
1 |
|
psychosurgery |
1 |
|
pterional access |
1 |
|
publish or perish |
1 |
|
rat |
1 |
|
reaction time task |
1 |
|
ref |
1 |
|
reinforcement |
1 |
|
rent-seeking behavior |
1 |
|
research productivity |
1 |
|
retina |
1 |
|
review |
1 |
|
scientists |
1 |
|
scopolamine |
1 |
|
serotonergic system |
1 |
|
serotonin |
1 |
|
serotonin (5-ht) |
1 |
|
serotonin (5-ht, 5-hydroxytryptamine) |
1 |
|
sex differences |
1 |
|
smad |
1 |
|
spatial |
1 |
|
stress |
1 |
|
stress hormone |
1 |
|
striatum |
1 |
|
subependymal plexus |
1 |
|
substantia nigra pars compacta |
1 |
|
subthalamic nucleus |
1 |
|
subthalamic nucleus (stn) |
1 |
|
subventricular zone |
1 |
|
synthetic drug |
1 |
|
tau |
1 |
|
tdcs |
1 |
|
technology |
1 |
|
temporomandibular articulation |
1 |
|
tes |
1 |
|
tetratricopeptide repeat domain 9a (ttc9a) |
1 |
|
tgf-β |
1 |
|
thalamus |
1 |
|
tourette syndrome |
1 |
|
traditional medicine |
1 |
|
transcorneal electrical stimulation |
1 |
|
transcranial direct current stimulation |
1 |
|
transcranial magnetic stimulation |
1 |
|
transcranial stimulation |
1 |
|
transgenic rats |
1 |
|
traumatic brain injury |
1 |
|
treatment resistant depression |
1 |
|
tyrosine |
1 |
|
tyrosine hydroxylase |
1 |
|
tyrosine hydroxylase (th) |
1 |
|
unfolded protein response |
1 |
|
vagal nerve stimulation |
1 |
|
ventral tegmental area |
1 |
|
ventrolateral thalamic nucleus |
1 |
|
ventromedial hypothalamus |
1 |
|
ventromedial prefrontal cortex |
1 |
|
ventromedial prefrontal cortex (vmpfc) |
1 |
